Sarah J. Tabrizi
UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 270 publications
Targeting toxic HTT1a could be the key to treating Huntington disease.
Journal: Nature reviews. Neurology
Published: May 26, 2026
Early Longitudinal Brain Network Changes in Huntington's Disease Before Clinical Motor Onset.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: March 31, 2026
Genetic or pharmacological disruption of the MSH3 Y245/K246 IDL binding pocket slows CAG repeat expansion.
Journal: NAR molecular medicine
Published: February 25, 2026
Huntington's disease clinical trials update: October 2025.
Journal: Journal of Huntington's disease
Published: November 26, 2025
Huntington disease: somatic expansion, pathobiology and therapeutics.
Journal: Nature reviews. Neurology
Published: October 03, 2025
Generation of C9orf72 repeat knock-in iPSC lines for modelling ALS and FTD.
Journal: bioRxiv : the preprint server for biology
Published: October 01, 2025
Mapping Regional Brain Aging in Huntington's Disease Using Structural Magnetic Resonance Imaging and Machine Learning.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: September 07, 2025
Bias in HD-ISS staging introduced by the FreeSurfer cross-sectional stream: Insights from the Huntington's Disease Young Adult Study (HD-YAS).
Journal: Journal of Huntington's disease
Published: August 13, 2025
Discovery of disrupted sustained attention and altered functional connectivity in far-from-onset Huntington's disease gene-expanded young adults.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: July 30, 2025
Cerebrospinal Fluid Proenkephalin Predicts Striatal Atrophy Decades before Clinical Motor Diagnosis in Huntington's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: June 24, 2025
Oral splicing modulator branaplam in Huntington's disease: a phase 2 randomized controlled trial.
Journal: Nature medicine
Published: June 16, 2025
Quantitative relationship between tominersen concentrations in cerebrospinal fluid and biomarker changes in Huntington's disease patients.
Journal: British journal of clinical pharmacology
Published: June 10, 2025
Last Updated: 09/26/2026